BackTable Tumor Board
BackTable Tumor Board
Podcast Description
BackTable Tumor Board is a multi-disciplinary podcast for healthcare professionals that play an active role in cancer care. Season One features in-depth conversations on the topic of Hepatocellular Carcinoma (HCC) provided by a group of medical oncologists, interventional radiologists, hepatobiliary surgeons, hepatologists, and patient coordinators. Stay tuned for the next season!
Podcast Insights
Content Themes
The podcast explores various aspects of hepatocellular carcinoma, including treatment options, complex case discussions from tumor board meetings, and insights on the role of surgery, interventional oncology, and transplantation. Episodes feature detailed case reviews, such as the principles of practice in HCC tumor boards and tips for starting a career in interventional oncology.
BackTable Tumor Board is a multi-disciplinary podcast for healthcare professionals that play an active role in cancer care.
Inflammatory breast cancer (IBC) is rare but highly aggressive, and often hides in plain sight. Rather than presenting as the distinct lump, IBC typically appears as redness or swelling in the breast and skin changes that can mimic mastitis or infection, leading to dangerous delays in diagnosis. In this episode of BackTable Tumor Board, breast medical oncologists Dr. Lindsay Peterson and Dr. Bora Lim break down how to recognize IBC’s typical and atypical presentations, approach diagnostic workup, and tailor treatment across subtypes.
—
SYNPOSIS
Dr. Peterson and Dr. Lim explore evolving neoadjuvant strategies, emerging clinical trials, combination therapies, IBC vaccine development, and the growing role of AI and MRI pattern recognition in predicting recurrence and guiding surveillance. The discussion highlights the importance of multidisciplinary expertise and calls for broader clinician awareness–especially in primary care, dermatology, and urgent care–so that persistent “infection-like” breast changes prompt timely evaluation and treatment for IBC.
—
TIMESTAMPS
0:00 – Introduction
3:26 – Typical Presentations of Inflammatory Breast Cancer (IBC)
8:30 – Atypical Presentations of IBC
11:48 – Routine Diagnostic Workup
16:06 – Treatments for Different Subtypes of IBC
19:49 – Clinical Trials
22:53 – Surveillance for Different Stages of IBC
25:59 – Current Clinical Trials for Best Treatments
29:18 – Central Nervous System Recurrence and Other Relapse Patterns in IBC
33:29 – Novel Neoadjuvant Therapy
37:27 – Centers Dedicated to Treating IBC
42:13 – Final Thoughts
—
RESOURCES
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer
https://clinicaltrials.gov/study/NCT03202316?tab=researcher#study-record-dates
Dana-Farber Cancer Institute
https://www.dana-farber.org/cancer-care/treatment/breast-oncology/programs/inflammatory-breast-cancer
MD Anderson Inflammatory Breast Cancer Clinic
https://www.mdanderson.org/patients-family/diagnosis-treatment/care-centers-clinics/breast-center/inflammatory-breast-cancer-clinic.html
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.